Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06961266 · ClinicalTrials.gov registry record · Phase 1

A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1

A Phase 1 study of Narcolepsy, sponsored by Jazz Pharmaceuticals.

Recruiting
Registry status
Phase 1
Development phase
8
Enrollment target
4
Study locations

NCT06961266 is a Phase 1 study of Narcolepsy that is actively recruiting participants, run by Jazz Pharmaceuticals. The registered enrollment target is 8 participants, below the 380-participant average among 12 other Narcolepsy trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06961266, a Phase 1 study of Narcolepsy, is actively recruiting participants, sponsored by Jazz Pharmaceuticals.

RECRUITING
Registry status
Phase 1
Development phase
8 participants
Enrollment target
4
Study locations

Study Summary

Narcolepsy is a sleep disorder in which patients are not able to maintain wakefulness or require treatment to maintain wakefulness during the daytime. Narcolepsy is a lifelong neurologic disease for which no cure has been clinically available. JZP441 is currently being developed for the treatment of narcolepsy type 1 (NT1). This study will assess the safety of efficacy of JZP441 in adult patients with NT1.

Conditions Studied

Narcolepsy

Interventions

  • DRUG Matching Placebo
  • DRUG JZP441

Study Locations (4)

Georgia

  • Clinical Trial Site - Atlanta

Ohio

  • Clinical Trial Site - Cincinnati

South Carolina

  • Clinical Trial Site - Columbia

Texas

  • Clinical Trial Site - Austin

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2025-05-13
Est. Completion 2026-04-01
Phase Phase 1

Sponsor

Jazz Pharmaceuticals

128 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06961266

The ClinicalTrials.gov registry entry for NCT06961266 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 380-participant average among 12 other Narcolepsy trials with a reported enrollment target (98% lower). The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Narcolepsy appearing as the primary indexed condition, and to 2 interventions - of which Matching Placebo is the first listed.

NCT06961266 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Georgia, Ohio, South Carolina.

Frequently Asked Questions

What is clinical trial NCT06961266 about?

NCT06961266 is a clinical study titled "A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1". Narcolepsy is a sleep disorder in which patients are not able to maintain wakefulness or require treatment to maintain wakefulness during the daytime. Narcolepsy is a lifelong neurologic disease for which no cure has been clinically available. JZP441 is currently being developed for the treatment of...

What is the current status of trial NCT06961266?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2025-05-13. Estimated completion is 2026-04-01.

What conditions does trial NCT06961266 study?

This clinical trial studies the following conditions: Narcolepsy.

What interventions are being tested in trial NCT06961266?

The interventions under investigation include: Matching Placebo (DRUG), JZP441 (DRUG).

Who is sponsoring clinical trial NCT06961266?

This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06961266 being conducted?

This trial has 4 study locations across Georgia, Ohio, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Narcolepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Narcolepsy

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.